CooperSurgical Fertility and Genomic Solutions has launched the CooperGenomics PGTai technology platform and the ERPeak endometrial receptivity test. Both will be available in North American from November 1 and internationally starting in January 2019.
The PGTai platform uses artificial intelligence and machine learning to improve the analysis, interpretation, and reporting of preimplantation genetic testing for aneuploidies (PGT-A). It is built on data from more than 1,000 biopsies that led to healthy babies. To validate the platform, the company analyzed sequencing data from more than 10,000 embryos and 5 million data points.
The ERPeak endometrial receptivity test detects the receptivity status of a woman's endometrium accurately and reliably. It measures the expression of several relevant hormone-regulated genes.